Syndax Pharmaceuticals, a biopharmaceutical company listed on Nasdaq under the ticker symbol SNDX, disclosed on July 28, 2026, its plans to unveil the financial results for the second quarter of 2026 along with a business update. The announcement stated that the details will be shared on Tuesday, August 4, 2026. Syndax Pharmaceuticals focuses on developing cutting-edge cancer treatments and is currently in the commercial stage of operations.